Extended Data Fig. 3: VCN kinetics (c/dg) in SCD patients.
From: Long-term outcomes of lentiviral gene therapy for the β-hemoglobinopathies: the HGB-205 trial
(a) In blood cell sub-populations. The values are investigator’s provided and are lower than the qualified values in Extended Data Table 1, due to different standards; they are provided here to compare VCN in cell sub-fractions in a time-dependent manner. (b) In erythroid burst-forming units (BFU-E). (c) In granulocyte-macrophage colony-forming units (CFU-GM).
